| Aktsiad | 585,25 B | — | KO KoAct | 0,00 | Tervishoiu | | 3.8.2023 | 21 596,80 | 8,05 | 37,04 |
TE | Aktsiad | 257,3 B | — | TE Tiger ETF | 0,40 | Tervishoiu | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 7.10.2020 | 7050,18 | 6,03 | 51,44 |
KO | Aktsiad | 214,6 B | — | KO Kodex | 0,45 | Tervishoiu | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 8127,82 | 5,44 | 37,93 |
TE | Aktsiad | 145,6 B | — | TE Tiger ETF | 0,40 | Tervishoiu | KRX Healthcare - KRW | 18.7.2011 | 36 545,56 | 4,63 | 39,62 |
TE | Aktsiad | 105,9 B | — | TE Tiger ETF | 0,30 | Tervishoiu | NASDAQ / Biotechnology | 27.8.2014 | 34 290,90 | 4,88 | 21,01 |
| Aktsiad | 71,7 B | — | KR KB RISE | 0,00 | Tervishoiu | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 15 679,68 | 9,56 | 68,04 |
KO | Aktsiad | 67,5 B | — | KO Kodex | 0,09 | Tervishoiu | KRX Healthcare - KRW | 28.3.2017 | 16 539,33 | 4,63 | 39,65 |
KO | Aktsiad | 61,4 B | — | KO KODEX | 0,25 | Tervishoiu | S&P Health Care Select Sector | 21.3.2023 | 13 619,17 | 4,86 | 22,50 |
TE | Aktsiad | 53,9 B | — | TE Tiger ETF | 0,40 | Tervishoiu | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 15.12.2016 | 11 805,61 | 10,44 | 59,10 |
TE | Aktsiad | 44,5 B | — | TE Tiger ETF | 0,45 | Tervishoiu | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10 059,99 | 7,96 | 17,83 |
TE | Aktsiad | 43,8 B | — | TE Tiger ETF | 0,49 | Tervishoiu | Solactive China Biotech Index | 8.12.2020 | 8198,18 | 4,03 | 28,69 |
SP | Aktsiad | 43,35 B | 9,89 M | SP SPDR | 0,08 | Tervishoiu | S&P Health Care Select Sector | 16.12.1998 | 167,13 | 4,86 | 22,63 |
KO | Aktsiad | 42,66 B | — | KO KODEX | 0,45 | Tervishoiu | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10 794,98 | 5,08 | 12,43 |
TE | Aktsiad | 31,7 B | — | TE Tiger ETF | 0,40 | Tervishoiu | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 19 216,88 | 2,91 | 30,55 |
TE | Aktsiad | 30,2 B | — | TE Tiger ETF | 0,40 | Tervishoiu | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 1.7.2016 | 25 215,38 | 0,00 | 0,00 |
| Aktsiad | 28,45 B | — | HW Hwabao | 0,60 | Tervishoiu | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,34 | 3,08 | 30,88 |
KO | Aktsiad | 25 B | — | KO Kodex | 0,25 | Tervishoiu | S&P Biotechnology Select Industry | 31.10.2013 | 47 089,42 | 0,00 | 0,00 |
VA | etf_assetclass_Sector Equity | 20,9 B | 239 399 | VA Vanguard | 0,09 | Tervishoiu | MSCI US IMI 25/50 Health Care | 26.1.2004 | 313,26 | 5,01 | 23,09 |
EF | Aktsiad | 17,42 B | — | EF E Fund | 0,00 | Tervishoiu | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,37 | 3,40 | 26,67 |
NH | Aktsiad | 16 B | — | NH NH-Amundi | 0,00 | Tervishoiu | | 26.11.2024 | 14 892,57 | 5,00 | 44,18 |
| Aktsiad | 14,21 B | — | KO KoAct | 0,50 | Tervishoiu | | 11.11.2025 | 10 338,06 | 5,59 | 22,65 |
| Aktsiad | 12,6 B | — | KR KB RISE | 0,00 | Tervishoiu | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 16 773,64 | 4,73 | 37,18 |
SP | Aktsiad | 11,33 B | 8,75 M | SP SPDR | 0,35 | Tervishoiu | S&P Biotechnology Select Industry | 31.1.2006 | 161,92 | 5,08 | 0,00 |
IS | Aktsiad | 10,73 B | 1,55 M | IS IShares | 0,44 | Tervishoiu | NYSE Biotechnology (TR) | 4.2.2001 | 211,92 | 5,10 | 21,90 |
| Aktsiad | 9,16 B | — | AC ACE | 0,30 | Tervishoiu | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12 860,55 | 7,21 | 21,79 |
KI | Aktsiad | 8,41 B | — | KI Kiwoom | 0,49 | Tervishoiu | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 12 779,55 | 0,00 | 0,00 |
| Aktsiad | 8,18 B | — | AC ACE | 0,45 | Tervishoiu | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 12 381,65 | 3,60 | 21,75 |
| Aktsiad | 7,94 B | — | KO KoAct | 0,00 | Tervishoiu | | 27.1.2026 | 10 133,67 | 4,34 | 29,64 |
| Aktsiad | 6,85 B | — | KO KoAct | 0,50 | Tervishoiu | | 3.9.2024 | 12 841,88 | 4,21 | 17,95 |
BO | Aktsiad | 6,66 B | — | BO Bosera | 0,65 | Tervishoiu | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,61 | 2,75 | 12,80 |
CH | Aktsiad | 6,37 B | — | CH ChinaAMC | 0,65 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,82 | 3,00 | 21,32 |
TE | Aktsiad | 6,1 B | — | TE Tiger ETF | 0,50 | Tervishoiu | FnGuide Medical Device Index - KRX - Benchmark TR Net | 8.11.2018 | 12 236,79 | 2,77 | 23,45 |
KI | Aktsiad | 5,93 B | — | KI Kiwoom | 0,49 | Tervishoiu | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 652,44 | 4,37 | 17,87 |
| Aktsiad | 5,69 B | — | MA Maxwealth | 0,60 | Tervishoiu | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,49 | 2,64 | 31,06 |
| Aktsiad | 5,44 B | — | NI Nippon | 0,19 | Tervishoiu | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
NF | Aktsiad | 5,44 B | — | NF NEXT FUNDS | 0,32 | Tervishoiu | | 21.3.2008 | 33 088,93 | 1,86 | 21,64 |
| Aktsiad | 5,15 B | — | KR KB RISE | 0,35 | Tervishoiu | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9602,93 | 7,72 | 19,09 |
TE | Aktsiad | 4,91 B | — | TE Tiger ETF | 0,40 | Tervishoiu | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0,00 | 0,00 |
IN | Aktsiad | 4,86 B | — | IN Invesco | 0,00 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,69 | 3,45 | 24,62 |
IC | Aktsiad | 4,74 B | — | IC ICBC | 0,00 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,24 | 0,00 | 0,00 |
IS | Aktsiad | 4,31 B | 221 505 | IS IShares | 0,38 | Tervishoiu | S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net | 12.11.2001 | 104,86 | 4,19 | 21,81 |
EF | Aktsiad | 4,02 B | — | EF E Fund | 0,00 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,18 | 0,00 | 0,00 |
GU | Aktsiad | 3,73 B | — | GU Guotai | 0,60 | Tervishoiu | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1,00 | 0,00 | 0,00 |
IS | Aktsiad | 3,69 B | 776 659 | IS IShares | 0,37 | Tervishoiu | Russell 1000 Health Care RIC 22.5/45 Capped Index | 11.6.2000 | 72,44 | 4,86 | 22,76 |
FI | Aktsiad | 3,48 B | 204 277 | FI Fidelity | 0,08 | Tervishoiu | MSCI US IMI 25/50 Health Care | 21.10.2013 | 81,29 | 4,77 | 22,64 |
XT | Aktsiad | 3,47 B | 59 533 | XT Xtrackers | 0,25 | Tervishoiu | MSCI World Index / Health Care -SEC | 4.3.2016 | 52,83 | 4,44 | 21,81 |
IS | Aktsiad | 3,38 B | 2,81 M | IS IShares | 0,37 | Tervishoiu | DJ US Select / Medical Equipment | 30.4.2006 | 53,65 | 3,79 | 29,41 |
FU | Aktsiad | 3,15 B | — | FU Fullgoal | 0,60 | Tervishoiu | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,44 | 0,00 | 0,00 |
IS | Aktsiad | 3,04 B | 544 280 | IS IShares | 0,15 | Tervishoiu | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 19.11.2015 | 13,83 | 4,86 | 22,63 |
FT | etf_assetclass_Sector Equity | 2,9 B | 68 677 | FT First Trust | 0,55 | Tervishoiu | NYSE Arca Biotechnology Index | 19.6.2006 | 265,88 | 3,45 | 22,71 |
NH | Aktsiad | 2,73 B | — | NH NH-Amundi | 0,45 | Tervishoiu | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9115,65 | 3,43 | 26,31 |
| Aktsiad | 2,46 B | — | HW Hwabao | 0,00 | Tervishoiu | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,49 B | 0,00 | 0,00 |
| Aktsiad | 2,35 B | — | IP ICICI Prudential IETF | 0,13 | Tervishoiu | Nifty Healthcare Index - INR - Benchmark TR Gross | 18.5.2021 | 170,24 | 5,10 | 34,66 |
GU | Aktsiad | 2,3 B | — | GU Guotai | 0,60 | Tervishoiu | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,42 | 3,08 | 30,90 |
CH | Aktsiad | 2,21 B | — | CH ChinaAMC | 0,75 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
CH | Aktsiad | 2,21 B | — | CH ChinaAMC | 0,75 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
HA | Aktsiad | 2,01 B | 409 852 | HA Harvest | 0,85 | Tervishoiu | | 18.12.2014 | 7,22 | 5,01 | 23,83 |
PA | Aktsiad | 1,82 B | — | PA Ping An | 0,60 | Tervishoiu | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 4,13 | 25,07 |
IS | Aktsiad | 1,67 B | 212 576 | IS IShares | 0,37 | Tervishoiu | DJ US Select / Pharmaceutical | 30.4.2006 | 104,67 | 4,59 | 21,41 |
EF | Aktsiad | 1,62 B | — | EF E Fund | 0,20 | Tervishoiu | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,11 | 2,50 | 20,25 |
AM | Aktsiad | 1,49 B | — | AM Amundi | 0,50 | Tervishoiu | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9937,75 | 2,82 | 14,76 |
IS | Aktsiad | 1,48 B | 23 130 | IS IShares | 0,41 | Tervishoiu | S&P Global 1200 Healthcare Sector Index - AUD | 12.11.2001 | 143,48 | 0,00 | 0,00 |
EF | Aktsiad | 1,45 B | — | EF E Fund | 0,20 | Tervishoiu | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,40 | 4,40 | 29,55 |
EF | Aktsiad | 1,44 B | — | EF E Fund | 0,20 | Tervishoiu | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,50 | 2,80 | 29,20 |
IS | Aktsiad | 1,4 B | 104 469 | IS IShares | 0,40 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 7.9.2016 | 10,63 | 3,82 | 20,92 |
CA | Aktsiad | 1,39 B | — | CA Cathay | 1,05 | Tervishoiu | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,22 | 3,39 | 17,66 |
IS | Aktsiad | 1,33 B | 518 377 | IS IShares | 0,37 | Tervishoiu | DJ US Select / Health Care Providers | 30.4.2006 | 57,37 | 2,30 | 16,34 |
EF | Aktsiad | 1,32 B | — | EF E Fund | 0,20 | Tervishoiu | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,68 | 3,14 | 28,62 |
GU | Aktsiad | 1,31 B | — | GU Guotai | 0,60 | Tervishoiu | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,95 | 0,00 | 0,00 |
IS | Aktsiad | 1,2 B | 96 285 | IS IShares | 0,40 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 7.9.2016 | 9,14 | 3,82 | 20,92 |
IS | Aktsiad | 1,17 B | 187 605 | IS IShares | 0,35 | Tervishoiu | NASDAQ / Biotechnology | 18.10.2017 | 10,55 | 0,00 | 0,00 |
FT | etf_assetclass_Sector Equity | 1,14 B | 45 884 | FT First Trust | 0,61 | Tervishoiu | StrataQuant Health Care Index | 8.5.2007 | 130,73 | 3,02 | 17,23 |
HA | Aktsiad | 1,13 B | — | HA Harvest | 0,60 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,91 | 0,00 | 0,00 |
AM | Aktsiad | 1,06 B | 173 | AM Amundi | 0,30 | Tervishoiu | MSCI World Index / Health Care -SEC | 19.8.2010 | 593,18 | 7,37 | 31,30 |
FT | etf_assetclass_Sector Equity | 1,05 B | 561 727 | FT First Trust | 0,60 | Tervishoiu | Nasdaq US Smart Pharmaceuticals Index | 20.9.2016 | 40,85 | 4,73 | 18,68 |
PB | Aktsiad | 1,02 B | 122 273 | PB Portfolio Building Block ETFs | 0,13 | Tervishoiu | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 24.11.2025 | 28,15 | 4,93 | 20,32 |
VA | Aktsiad | 1,01 B | 254 130 | VA VanEck | 0,36 | Tervishoiu | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 110,44 | 4,92 | 18,95 |
GX | Aktsiad | 977,46 M | — | GX Global X | 0,59 | Tervishoiu | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1739,46 | 1,90 | 19,17 |
XT | Aktsiad | 942,32 M | 8946 | XT Xtrackers | 0,12 | Tervishoiu | MSCI USA / Health Care -SEC | 12.9.2017 | 66,92 | 5,07 | 22,81 |
CS | Aktsiad | 926,44 M | — | CS CSOP | 1,50 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,75 | 3,33 | 23,96 |
AM | Aktsiad | 914,73 M | 727 | AM Amundi | 0,30 | Tervishoiu | MSCI World Index / Health Care -SEC | 19.8.2010 | 510,04 | 7,68 | 29,88 |
| Aktsiad | 897,71 M | — | WA Wanjia | 0,00 | Tervishoiu | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,62 | 3,45 | 24,62 |
AM | Aktsiad | 877,54 M | 13 563 | AM Amundi | 0,30 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 21.3.2024 | 147,63 | 2,85 | 19,76 |
AM | Aktsiad | 877,54 M | 264 | AM Amundi | 0,30 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 21.3.2024 | 187,45 | 2,98 | 20,61 |
IN | Aktsiad | 843,62 M | 149 006 | IN Invesco | 0,40 | Tervishoiu | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 36,50 | 3,04 | 19,91 |
AM | Aktsiad | 753,55 M | 2043 | AM Amundi | 0,30 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 21.3.2024 | 126,77 | 2,85 | 19,76 |
IS | Aktsiad | 740,26 M | 89 522 | IS IShares | 0,18 | Tervishoiu | MSCI Europe Health Care 20/35 Capped Index - EUR | 16.11.2020 | 6,10 | 3,73 | 19,22 |
CA | Aktsiad | 721,53 M | — | CA Cathay | 0,41 | Tervishoiu | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,05 | 0,00 | 0,00 |
IS | Aktsiad | 703,77 M | 6437 | IS IShares | 0,46 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 24.4.2001 | 112,16 | 3,63 | 19,15 |
XT | Aktsiad | 695,37 M | 18 393 | XT Xtrackers | 0,12 | Tervishoiu | MSCI USA / Health Care -SEC | 12.9.2017 | 49,38 | 5,07 | 22,81 |
SP | Aktsiad | 694,19 M | 16 936 | SP SPDR | 0,30 | Tervishoiu | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 28.2.2009 | 70,97 | 4,44 | 21,81 |
GX | Aktsiad | 681,52 M | 29 473 | GX Global X | 0,68 | Tervishoiu | Solactive China Biotech Index | 24.7.2019 | 74,08 | 4,18 | 30,21 |
GX | Aktsiad | 681,52 M | — | GX Global X | 0,68 | Tervishoiu | Solactive China Biotech Index | 24.7.2019 | 74,08 | 4,18 | 30,21 |
SP | Aktsiad | 616,33 M | 101 277 | SP SPDR | 0,35 | Tervishoiu | S&P Pharmaceuticals Select Industry | 19.6.2006 | 70,44 | 3,51 | 16,73 |
CS | Aktsiad | 615,18 M | — | CS China Southern | 0,65 | Tervishoiu | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,10 | 2,98 | 21,35 |
IS | Aktsiad | 612,63 M | 66 400 | IS IShares | 0,18 | Tervishoiu | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 16.10.2019 | 7,10 | 4,16 | 22,04 |
SP | Aktsiad | 561,27 M | 2171 | SP SPDR | 0,18 | Tervishoiu | MSCI Europe Health Care Index - EUR | 30.9.2001 | 220,76 | 3,73 | 19,22 |
IN | Aktsiad | 553,12 M | 31 033 | IN Invesco | 0,58 | Tervishoiu | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 126,57 | 3,12 | 18,42 |
| Aktsiad | — | 74 704 | LE LeverageShares | 0,00 | Tervishoiu | iSTOXX Inverse Leveraged -3x MRNA Index - Benchmark TR Net | 10.12.2021 | 0,11 | 0,00 | 0,00 |
LS | Aktsiad | — | — | LS Leverage Shares | 0,01 | Tervishoiu | Euronext -3X Short Eli Lilly Index - Benchmark TR Net | 16.9.2025 | 7,67 | 0,00 | 0,00 |